Everspin technologies CFO William Cooper sells $239,250 in stock

Everspin Technologies reported Q1 2026 EPS of $0.40, sharply above the $0.01 consensus, and revenue of $14.9 million versus $14.63 million expected. Needham raised its price target to $18.50 from $14.00 while maintaining a Buy rating, citing the earnings beat and stronger guidance. Offsetting that, CFO William Cooper sold 11,000 shares at $21.75 for $239,250 and now directly holds 161,030 shares.

Analysis

The bigger read-through is not the headline earnings beat, but that MRAM is transitioning from a “story stock” to a hybrid government-capex beneficiary with a more durable backlog profile. The defense contract matters because it should smooth revenue volatility, improve the mix toward higher-visibility engineering services, and give management more leverage in future bids if execution is clean over the next 2-3 quarters. That said, the stock’s move has likely already discounted a lot of this shift, especially with a near-peak valuation and insider selling into strength, which is often more about signaling than size.

The second-order effect is margin compression risk disguised as growth. Government programs can add revenue but not necessarily earnings quality if staffing, program ramp, and compliance overhead scale faster than gross profit; the market may be extrapolating the top-line win without fully modeling working-capital drag or subcontract concentration. If the company’s outperformance was partly driven by an unusual quarter, the stock is vulnerable to a “beat-and-hold” pattern rather than repeated upside surprises, which usually disappoints momentum holders within 1-2 earnings cycles.

Consensus seems to be treating the name as still undervalued because the analyst target sits below spot, but that can be a stale anchor when a stock has already rerated 3x in a year. The contrarian view is that the market is pricing in both a sustained fundamental inflection and continued multiple expansion, while the more likely path is earnings growth catching up to valuation rather than leading it. Any sign that defense revenue is lumpy, gross margin normalizes, or insider selling persists would be enough to cap further upside over the next 1-3 months.

Key Decisions for Investors

• Avoid initiating fresh longs in MRAM at current levels; if already long, trim 25-50% into strength and reassess after the next quarter, because the risk/reward is poor after a 266% one-year run.
• If seeking exposure, buy MRAM on a 10-15% post-earnings pullback only if the company confirms backlog conversion and margin stability; target a 2:1 upside/downside setup rather than chasing momentum.
• For event-driven traders, consider a short-dated call spread sale on MRAM into any further spike over the next 2-4 weeks; the position benefits from valuation mean reversion and insider-sale overhang, with defined risk.
• Pair trade idea: long a higher-quality defense-electronics beneficiary with recurring visibility and short MRAM over the next 1-3 months to isolate multiple compression risk versus real backlog durability.
• Set a catalyst monitor for the next earnings print and contract updates over the next 1-2 quarters; if revenue growth slows or margin misses by >200 bps, expect a sharp de-rating from momentum holders.